LZLiduan Zheng

Liduan Zheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Liduan Zheng has a total of 171 co-authors. Here are the top co-authors by number of shared publications:

  • Qiangsong Tong

    Department of Pediatric Surgery, Union Hospital, Tongji Medical College Huazhong University of Science and Technology 1277 Jiefang Avenue Wuhan Hubei Province 430022 P. R. China

    59 shared publications
  • Dan Li

    Department of Pediatric Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, P. R. China

    28 shared publications
  • Xiaojing Wang

    Department of Pediatric Surgery Tongji Medical College Union Hospital Huazhong University of Science and Technology 1277 Jiefang Avenue 430022 Wuhan Hubei Province P. R. China

    26 shared publications
  • Kai Huang

    Clinical Center of Human Genomic Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China

    16 shared publications
  • Jianqun Wang

    Department of Pediatric Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan 430022, Hubei Province, PR China

    15 shared publications
  • Hong Mei

    14 shared publications

Latest Publications

  • Open Access

    A hepatic solitary fibrous tumor with giant cells and a review of the literature

    by Bosen Zhao, Shunchen Zhou, Jiaying Qu, Xingyu Gao, Xiaolin Wang, Chunhui Yang, Qiangsong Tong, Liduan Zheng

    Background Solitary fibrous tumor (SFT) is a rare mesenchymal tumor usually occurring at the pleura. Primary hepatic SFT presents at the liver is extremely rare, and its nonspecific clinical-biological findings cause a considerable difficulty in differentiation from other hepatic tumors. Case presentation We reported a uncommon case of primary hepatic SFT, which was pathologically characterized by abundant multinucleated giant cells. A man in his 60 s was admitted for a long-standing right upper abdominal pain (more than several months). Magnetic resonance imaging (MRI) scan revealed a mass in the liver. A right hemihepatectomy was performed and the pathological diagnosis revealed a tumor consisting of spindle-shaped tumor cells arranged in various forms with the presence of sparsely scattered numerous giant cells. Based on immunohistochemical staining (STAT6 + /CD34 +) and the WHO risk stratification criteria (high-risk category, score 7), the tumor was diagnosed as primary hepatic malignant SFT with giant cells. The patient recovered after the surgery and was administrated to regular lenvatinib treatment without recurrence for a course of 25 months. Conclusion The hepatic SFT with giant cells (SFT-gc) is an exceedingly rare variant of primary hepatic SFT. Because of its anatomic atypia, careful distinction should be made from other frequent hepatic tumors, and a high index of suspicion is essential for accurate histopathological diagnosis.

  • Open Access

    Dual targeting of AMRC12 and Malassezia globosa disrupts MYC liquid condensates-driven nuclear pore complex biogenesis in neuroblastoma

    by Anpei Hu, Chunhui Yang, Zhijie Wang, Xiaolin Wang, Xinyue Li, Shunchen Zhou, Bosen Zhao, Jiaying Qu, Xiaojing Wang, Liduan Zheng, et al.

    Rationale: Neuroblastoma (NB) is a predominant extra-cranial malignancy in childhood, while molecular drivers of its progression and effective treatment strategies have yet to be clarified. Methods: RNA sequencing was performed to identify transcriptional regulators and corresponding target genes. To explore the biological effects and underlying mechanisms of these regulators, a comprehensive methodology was utilized, encompassing chromatin immunoprecipitation, dual-luciferase reporter assay, qRT-PCR, western blot, alongside gene over-expression and silencing techniques, co-immunoprecipitation, and mass spectrometry. The MTT assay, soft agar colony formation, Matrigel invasion, and nude mouse xenograft models were applied to assess oncogenic properties. Patient survival was analyzed using the log-rank test. Results: Armadillo repeat containing 12 (ARMC12) was identified as a MYC-interacting modulator within liquid condensates to up-regulate critical nucleoporin-encoding targets (NUP62/NUP93/NUP98), which promoted nuclear pore complex (NPC) biogenesis to facilitate nuclear trafficking of oncogenic effectors, thereby enhancing invasion and metastasis of NB. As a protein within extracellular vesicles of Malassezia globosa colonizing NB tissues, MGL_0381 also facilitated MYC transactivation via physical interaction to accelerate NPC biogenesis and NB progression. Tioconazole (TCZ) and UU-T02 were identified as efficient inhibitors blocking ARMC12-MYC and MGL_0381-MYC interaction, and synergistically reduced NPC number and aggressive features of NB. High ARMC12, MYC, NUP62, NUP93, or NUP98 levels served as markers of unfavorable patient outcomes in clinical cohorts. Conclusions: These findings collectively demonstrate that dual targeting of AMRC12 and Malassezia globosa disrupts MYC liquid condensates-driven NPC biogenesis during NB progression.


  • Open Access

    Association between cholecystectomy and colorectal cancer: results from the National Health and Nutrition Examination Survey (NHANES) 2017–2023 and Mendelian randomization analyses

    by Shunchen Zhou, Bosen Zhao, Jiaying Qu, Xingyu Gao, Xiaolin Wang, Chunhui Yang, Qiangsong Tong, Liduan Zheng

    Background: Cholecystectomy is widely used to treat gallbladder disease, but its link to colorectal cancer (CRC) remains controversial. This study aimed to assess the association between cholecystectomy and CRC by combining cross-sectional analysis with Mendelian randomization (MR). Methods: We analyzed 12,490 adults from the National Health and Nutrition Examination Survey (NHANES) 2017–2023 for the association between cholecystectomy and CRC. Weighted logistic regression models with progressive adjustments were applied: Model 1 was unadjusted, Model 2 accounted for sociodemographic factors, while Model 3 was further controlled for lifestyle, diet, and comorbidities. Subgroup and sensitivity analyses were conducted to evaluate the results’ robustness. MR analysis further complemented the observational analysis and evaluated potential causality. Results: In the NHANES sample, cholecystectomy was not significantly associated with CRC after full adjustment [Model 3: odds ratio (OR) =2.06; 95% confidence interval (CI): 0.93–4.55; P=0.068], although crude and partially adjusted models showed positive associations (Model 1: OR =3.77, 95% CI: 2.08–6.83, PConclusions: No statistically significant overall association was observed between cholecystectomy and CRC in our analysis.


  • Open Access

    Nortriptyline Inhibits Lysosomal Exocytosis‐Mediated SASP During Gastric Cancer Progression via Targeting HOXA1‐PITX2 Phase Separation

    by Yi Zhou, Chunhui Yang, Xinyue Li, Xiaojing Wang, Wanju Jiao, Xiaolin Wang, Jiaying Qu, Bosen Zhao, Shunchen Zhou, Qiangsong Tong, et al.

    Lysosomal exocytosis, a calcium‐dependent secretory process, facilitates extracellular release of cargos that promote cancer progression, though its regulatory pathways and therapeutic strategies are poorly understood. Herein, using combined transcriptomic and proteomic approaches, we identify homeobox A1 (HOXA1) as a functional partner of paired like homeodomain 2 (PITX2) within biomolecular condensates forming via liquid–liquid phase separation. Mechanistically, HOXA1‐PITX2 complex facilitates the expression of mucolipin 1 (MCOLN1 ) and RAS‐related protein Rab‐3A ( RAB3A ), which drive lysosomal exocytosis of galectin‐1 (LGALS1) and insulin like growth factor binding protein 7 (IGFBP7) from senescent gastric cancer cells. This process potentiates AKT activation and epithelial‐mesenchymal transition, accelerating tumorigenesis and aggressiveness of gastric cancer. Molecular docking and affinity purification assays reveal nortriptyline (Nor) as a potent phase separation disruptor of HOXA1‐PITX2 complex. Preclinical studies demonstrate that Nor administration attenuates lysosomal exocytosis‐mediated senescence‐associated secretory phenotype (SASP) and reduces aggressive phenotypes in gastric cancer models, underscoring the HOXA1 / PITX2 axis as a critical regulator of gastric cancer progression. Clinically, elevated expression of HOXA1 , PITX2 , MCOLN1 , RAB3A , LGALS1 , and IGFBP7 constitutes a prognostic signature correlating with poor outcomes of gastric cancer patients. Collectively, these results indicate that Nor impedes gastric cancer progression by suppressing HOXA1‐PITX2 phase separation and subsequent lysosomal exocytosis‐mediated SASP.

  • Open Access

    Targeting RBM10‐Repressed RORB Activity in Liquid Condensates Inhibits Lysosomal Biogenesis and Neuroblastoma Progression via Affecting NF‐κB Signaling

    by Yanhua Guo, Xiaojing Wang, Chunhui Yang, Zhijie Wang, Xiaolin Wang, Xinyue Li, Jiaying Qu, Shunchen Zhou, Liduan Zheng, Qiangsong Tong

    Neuroblastoma (NB), a pediatric solid malignancy, is distinguished by hetergenous clinical characteristics, including tumor aggressiveness or spontaneous regression. Nevertheless, the regulatory mechanisms and therapeutic approaches underlying these processes are still mainly unknown. Herein, RAR‐related orphan receptor B (RORB) as a transcription factor repressing nuclear factor kappa B (NF‐κB) signaling involved in lysosomal biogenesis of NB. RORB attenuated the growth, invasiveness, and metastatic spread of NB cells are identified. From a mechanistic perspective, RORB increased the transcription of nuclear receptor subfamily 1 group D member 1 ( NR1D1 ) ‐ or RIO kinase 3 ( RIOK3 ) ‐ in a circadian clock‐dependent manner, resulting in suppression of NF‐κB activity, subsequent derepression of folliculin ( FLCN ) ‐ or folliculin interacting protein 1 ( FNIP1 ) ‐ levels, and decrease of lysosomal biogenesis in NB cells. Meanwhile, in liquid condensates, RNA binding motif protein 10 (RBM10) interacted with RORB to repress its transactivation and exerted oncogenic roles in lysosomal biogenesis and aggressiveness of NB cells. Pre‐clinically, a small peptide is able to block the interaction between RBM10 and RORB, and suppresses lysosomal biogenesis, tumorigenesis, and aggressiveness. High levels of RORB , NR1D1 , RIOK3 , FLCN , and FNIP1 , or low expression of RBM10 , are linked to favorable prognosis of clinical NB cases. These results indicate that targeting RBM10‐repressed RORB activity in liquid condensates inhibits lysosomal biogenesis and NB progression via affecting NF‐κB signaling.


  • Open Access

    CIAO1 as a crucial signature gene of cuproptosis in gastric cancer

    by Jiaying Qu, Chunhui Yang, Shunchen Zhou, Bosen Zhao, Qiangsong Tong, Liduan Zheng

    Gastric cancer is a global health challenge, necessitating the identification of novel biomarkers and therapeutic targets. The present study aimed to assess the role of cuproptosisrelated genes (CRGs) in gastric cancer, with the goal of establishing a predictive model consisting of key regulators with prognostic significance, thereby enabling the identification of key genes. Data from The Cancer Genome Atlas and Gene Expression Omnibus databases were used to analyze CRGs in stomach adenocarcinoma (STAD). Least absolute shrinkage and selection operator regression analysis was applied to create a risk model, and its predictive accuracy was confirmed for several clinical subgroups. Moreover, the prognostic value of essential regulators was evaluated through multiple analyses. A risk model with 15 CRGs was used to effectively predict STAD prognosis, demonstrating areas under the receiver operating characteristic curve values of 0.822, 0.811 and 0.922 for 1‑, 3‑ and 5‑year overall survival rates, respectively. The risk scores were associated with survival and tumor site. Among the CRGs, the gene for cytosolic iron‑sulfur assembly component 1 (CIAO1) was revealed to be critical and associated with histological type, age and treatment outcome. Moreover, single‑cell analysis demonstrated that CIAO1 is highly expressed in numerous types of cancer cells, and a high expression of CIAO1 was associated with upregulated transcription levels of immune checkpoints, increased tumor mutation load and decreased immune scores, highlighting its complex role in the tumor microenvironment. CIAO1 knockdown experiments were performed, and eliminating CIAO1 was associated with a reduction in the levels of iron‑sulfur proteins and an increase in heat shock protein 70 expression, thereby inducing copper‑dependent cell death. Furthermore, treatment with the drugs dasatinib and AT‑9283 were associated with an inhibition of CIAO1 expression in gastric cancer cells, and decreased rates of tumor spread and invasion. Taken together, the findings of the present study suggest that CIAO1 is a promising biomarker both for assessing prognosis and evaluating the tumor immune microenvironment of gastric cancer.


  • Open Access

    SNORA37/CMTR1/ELAVL1 feedback loop drives gastric cancer progression via facilitating CD44 alternative splicing

    by Banghe Bao, Minxiu Tian, Xiaojing Wang, Chunhui Yang, Jiaying Qu, Shunchen Zhou, Yang Cheng, Qiangsong Tong, Liduan Zheng

    Background: Emerging evidence shows that small nucleolar RNA (snoRNA), a type of highly conserved non-coding RNA, is involved in tumorigenesis and aggressiveness. However, the roles of snoRNAs in regulating alternative splicing crucial for cancer progression remain elusive. Methods: High-throughput RNA sequencing and comprehensive analysis were performed to identify crucial snoRNAs and downstream alternative splicing events. Biotin-labeled RNA pull-down, mass spectrometry, cross-linking RNA immunoprecipitation, and in vitro binding assays were applied to explore interaction of snoRNAs with protein partners. Alternative splicing and gene expression was observed by real-time quantitative RT-PCR and western blot assays. In vitro and in vivo studies were performed to investigate biological effects of snoRNAs and their protein partners in gastric cancer. Survival analysis was undertaken by using Kaplan-Meier method and log-rank test. Results: SNORA37 was identified as an up-regulated snoRNA essential for tumorigenesis and aggressiveness of gastric cancer. Gain- and loss-of-function studies indicated that SNORA37 promoted the growth, invasion, and metastasis of gastric cancer cells in vitro and in vivo. Mechanistically, as an ELAV like RNA binding protein 1 (ELAVL1)-generated snoRNA, SNORA37 directly bound to cap methyltransferase 1 (CMTR1) to facilitate its interaction with ELAVL1, resulting in nuclear retention and activity of ELAVL1 in regulating alternative splicing of CD44. Rescue studies revealed that SNORA37 exerted oncogenic roles in gastric cancer progression via facilitating CMTR1-ELAVL1 interaction. In clinical gastric cancer cases, high levels of SNORA37, CMTR1, ELAVL1, or CD44 were associated with shorter survival and poor outcomes of patients. Conclusions: These results indicated that SNORA37/CMTR1/ELAVL1 feedback loop drives gastric cancer progression via facilitating CD44 alternative splicing.


  • Open Access

    Targeting the Exonic Circular OGT RNA/O-GlcNAc Transferase/Forkhead Box C1 Axis Inhibits Asparagine- and Alanine-Mediated Ferroptosis Repression in Neuroblastoma Progression

    by Qilan Li, Yang Cheng, Chunhui Yang, Minxiu Tian, Xiaojing Wang, Dan Li, Xinyue Li, Jiaying Qu, Shunchen Zhou, Liduan Zheng, et al.

    The disruption of ferroptosis, an emerging form of programmed cell death, is crucial in the development and aggressiveness of tumors. Meanwhile, the mechanisms and treatments that control ferroptosis in neuroblastoma (NB), a prevalent extracranial cancer in children, are still unknown. In this study, forkhead box C1 (FOXC1) and O-GlcNAc transferase (OGT) are identified as regulators of asparagine- and alanine-mediated ferroptosis repression in NB. Mechanistically, OGT facilitates FOXC1 stabilization via inducing O-GlcNAcylation in liquid condensates to increase the expression of asparagine synthetase ( ASNS ) and glutamate pyruvate transaminase 2 ( GPT2 ), resulting in asparagine and alanine biogenesis, and subsequent synthesis of cystathionine β-synthase (CBS) or ferritin heavy chain 1 (FTH1). Meanwhile, exonic circular OGT RNA ( ecircOGT ) is able to encode a novel protein (OGT-570aa) containing domain essential for binding of OGT to FOXC1, which competitively decreases the OGT–FOXC1 interaction. Preclinically, miconazole nitrate facilitates the interaction of OGT-570aa with FOXC1, suppresses ferroptosis resistance of NB cells, and inhibits their growth, invasion, and metastasis. In clinical NB cases, higher OGT , FOXC1 , ASNS , GPT2 , CBS , or FTH1 levels are correlated with worse survival, while lower ecircOGT or OGT-570aa expression is associated with tumor progression. These results indicate that targeting the ecircOGT / OGT / FOXC1 axis inhibits asparagine- and alanine-mediated ferroptosis repression in NB progression.


  • Open Access

    YY1 drives PARP1 expression essential for PARylation of NONO in mRNA maturation during neuroblastoma progression

    by Chunhui Yang, Jiaying Qu, Yang Cheng, Minxiu Tian, Zhijie Wang, Xiaolin Wang, Xinyue Li, Shunchen Zhou, Bosen Zhao, Yanhua Guo, et al.

    Neuroblastoma (NB), the most prevalent solid tumor in children, arises from sympathetic nervous system and accounts for 15% of pediatric cancer mortality. This malignancy exhibits substantial genetic and clinical heterogeneity, thus complicating treatment strategies. Poly(ADP-ribose) polymerase 1 (PARP1), a key enzyme catalyzing polyADP-ribosylation (PARylation), plays critical roles in various cellular processes, and contributes to tumorigenesis and aggressiveness. However, the functions and regulatory mechanisms of PARP1 in NB progression still remain to be determined. The association of PARP1 expression with NB patients’ survival was analyzed by mining of R2 database. Western blotting, reverse transcription-polymerase chain reaction, MTT colorimetric, soft agar, and matrigel invasion assays were utilized to assess PARP1 expression and its effects on aggressiveness of NB cell lines. Chromatin immunoprecipitation (ChIP) sequencing and ChIP assays were employed to investigate the binding of Yin Yang 1 (YY1) to PARP1 promoter. Protein interactions were explored by BioGRID database analysis, molecular docking, and co-immunoprecipitation assay. RNA sequencing and crosslinking-immunoprecipitation high throughput sequencing datasets were used to identify precursor mRNA splicing targets of non-POU domain containing octamer binding protein (NONO). High PARP1 expression was associated with poor survival of NB patients. PARP1 over-expression enhanced the proliferation and invasion of NB cell lines, confirming its oncogenic roles. YY1 was identified as a key transcriptional regulator facilitating PARP1 expression. Additionally, PARP1 interacted with NONO to induce its PARylation, resulting in stabilization of NONO protein via preventing ubiquitin-mediated degradation. NONO facilitated the splicing and mRNA maturation of target genes a disintegrin and metalloproteinase domain 8 (ADAM8) and testis-expressed gene 14 (TEX14) in a PARylation-dependent manner. Rescue experiments indicated that YY1 facilitated PARP1-mediated PARylation of NONO and subsequent mRNA maturation of ADAM8 and TEX14 in NB cells. In clinical NB cases, high expression of YY1, PARP1, NONO, ADAM8, or TEX14 was associated with poor survival of patients. These findings indicate that YY1 drives PARP1 expression essential for PARylation of NONO in mRNA maturation during NB progression.


  • circE2F1-encoded peptide inhibits circadian machinery essential for nucleotide biosynthesis and tumor progression via repressing SPIB/E2F1 axis

    by Jianqun Wang, Xiaojing Wang, Chunhui Yang, Qilan Li, Dan Li, Xinyi Du, Yang Cheng, Minxiu Tian, Liduan Zheng, Qiangsong Tong